Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
Recurrence-free survival and overall survival were more common in patients with nevus-associated acral melanoma compared with ...
The next most difficult game is the actual Squid Game, the final challenge where Gi-hun and Sang-woo had to fight on a ...
Predicting need for nursing home care remains complex For clinicians it is an important and demanding task to inform patients with dementia and their relatives about the prognosis. As with malignant ...